UA90682C2 - Variant fc regions - Google Patents

Variant fc regions

Info

Publication number
UA90682C2
UA90682C2 UAA200700820A UAA200700820A UA90682C2 UA 90682 C2 UA90682 C2 UA 90682C2 UA A200700820 A UAA200700820 A UA A200700820A UA A200700820 A UAA200700820 A UA A200700820A UA 90682 C2 UA90682 C2 UA 90682C2
Authority
UA
Ukraine
Prior art keywords
variant
regions
antibody
amino acid
region
Prior art date
Application number
UAA200700820A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Барретт Аллан
Вейдун Цзян
Инь Тань
Джеффри Дин Уоткинс
Original Assignee
Аплайд Молекьюлер Иволюшн, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Аплайд Молекьюлер Иволюшн, Инк. filed Critical Аплайд Молекьюлер Иволюшн, Инк.
Publication of UA90682C2 publication Critical patent/UA90682C2/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to anti-CD20 antibody comprising a novel variant of Fc region with amino acid substitution, to a pharmaceutical composition and method for treating lymphoma with an anti-CD20 antibody.
UAA200700820A 2004-08-04 2005-07-18 Variant fc regions UA90682C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59885504P 2004-08-04 2004-08-04

Publications (1)

Publication Number Publication Date
UA90682C2 true UA90682C2 (en) 2010-05-25

Family

ID=50689249

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200700820A UA90682C2 (en) 2004-08-04 2005-07-18 Variant fc regions

Country Status (1)

Country Link
UA (1) UA90682C2 (en)

Similar Documents

Publication Publication Date Title
MX341883B (en) Pharmaceutical composition for treatment and prevention of cancer.
TW200714283A (en) Method and composition for treating peripheral vascular diseases
EP2331072A4 (en) Methods and compositions for oral administration of proteins
FR21C1004I1 (en)
RS20060320A (en) Substituted indazole-o-glucosides
MY142777A (en) Substituted indole-o-glucosides
UA87991C2 (en) Substituted indole-o-glucosides
MX2008012748A (en) A process for concentration of a polypeptide.
MX2014001372A (en) Pharmaceutical composition for treatment and/or prevention of pancreatic cancer.
TW200738270A (en) Method of treating depression using a TNFα antibody
MX2010006395A (en) Antibody formulation.
MX2010006823A (en) Methods for the treatment of gout.
IL195338A (en) Antibody comprising an fc variant comprising d or e amino acid substitution at position 239 and pharmaceutical composition and use thereof
EP2279244A4 (en) Methods and compositions for oral administration of proteins
WO2006033859A3 (en) Compositions and methods for protein production
SG166813A1 (en) 5-lipoxygenase-activating protein (flap) inhibitors
WO2008143954A3 (en) Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto
MX336725B (en) Method of modifying isoelectric point of antibody via amino acid substitution in cdr.
JO2576B1 (en) Antibodies
SG165387A1 (en) 5-lipoxygenase-activating protein (flap) inhibitors
MX2009012950A (en) Humanized antibodies to aãŸ(20-42) globulomer and uses thereof.
IL189452A0 (en) Therapy with cd4 binding peptides and radiation
TW200738751A (en) Anti-EphrinB2 antibodies and methods using same
UA99601C2 (en) Use of an anti-cd151 antibody in the treatment of cancer
PL1869185T3 (en) Conjugate comprising p21 protein for the treatment of cancer